{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:31:51Z","timestamp":1792474311111,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jneuroim.2023.578248","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T04:49:02Z","timestamp":1700282942000},"page":"578248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab"],"prefix":"10.1016","volume":"385","author":[{"given":"Kyriakoula","family":"Varmpompiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Westwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ben-Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Sibtain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biba","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Mantoan","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jneuroim.2023.578248_bb0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/neup.12599","article-title":"Progressive multifocal leukoencephalopathy in idiopathic CD4+ lymphocytopenia: a case report and review of literature","volume":"39","author":"Aggarwal","year":"2019","journal-title":"Neuropathology."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578248_bb0010","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s13365-018-0638-0","article-title":"Progressive multifocal leukoencephalopathy in idiopathic CD4+ lymphocytopenia","volume":"24","author":"Aghoram","year":"2018","journal-title":"J. Neurovirol."},{"issue":"8","key":"10.1016\/j.jneuroim.2023.578248_bb0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaneurol.2014.825","article-title":"Treatment of progressive multifocal leukoencephalopathy with interleukin 7","volume":"71","author":"Alstadhaug","year":"2014","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578248_bb0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2169\/internalmedicine.55.6649","article-title":"Progressive multifocal leukoencephalopathy localized in the cerebellum and brainstem associated with idiopathic CD4(+) T lymphocytopenia","volume":"55","author":"Aotsuka","year":"2016","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578248_bb0025","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ene.13906","article-title":"The spectrum of progressive multifocal leukoencephalopathy: a practical approach","volume":"26","author":"Bartsch","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578248_bb0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/B978-0-444-53488-0.00017-1","article-title":"Progressive multifocal leukoencephalopathy","volume":"123","author":"Berger","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578248_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.26512","article-title":"Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors","volume":"93","author":"Boumaza","year":"2023","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578248_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216892","article-title":"Response to: correspondence on \u201cImmune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation\u201d by Braaten et al","volume":"81","author":"Cappelli","year":"2022","journal-title":"Ann Rheum Dis."},{"issue":"10","key":"10.1016\/j.jneuroim.2023.578248_bb0045","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00415-019-09501-y","article-title":"Treatment of progressive multifocal leukoencephalopathy","volume":"266","author":"Castle","year":"2019","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578248_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/clinids\/24.3.526","article-title":"Idiopathic CD4+ T lymphocytopenia presenting as progressive multifocal leukoencephalopathy: case report","volume":"24","author":"Chikezie","year":"1997","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578248_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/QAD.0000000000003395","article-title":"Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS","volume":"37","author":"Coltart","year":"2023","journal-title":"AIDS."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578248_bb0060","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11904-022-00626-w","article-title":"Promise and challenges of checkpoint inhibitor therapy for progressive multifocal leukoencephalopathy in HIV","volume":"19","author":"Corey","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jneuroim.2023.578248_bb0065","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","article-title":"Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy","volume":"380","author":"Cortese","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"349","key":"10.1016\/j.jneuroim.2023.578248_bb0070","article-title":"\u201cBorderline\u201d idiopathic CD4+ T-cell lymphocytopenia presenting with atypical progressive multifocal leukoencephalopathy","volume":"15","author":"Dato","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2023.578248_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2013.02.002","article-title":"Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia","volume":"327","author":"Delgado-Alvarado","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578248_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S0036-46652012000400009","article-title":"Acute gouty arthritis as a manifestation of immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy","volume":"54","author":"Eyer-Silva Wde","year":"2012","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578248_bb0085","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/neup.12773","article-title":"\u201cBurnt-out\u201d progressive multifocal leukoencephalopathy in idiopathic CD4+ lymphocytopenia","volume":"41","author":"Fukumoto","year":"2021","journal-title":"Neuropathology."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578248_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","article-title":"Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression","volume":"81","author":"Gheuens","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jneuroim.2023.578248_bb0095","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.clineuro.2020.105923","article-title":"R P, Javali M, T Acharya P, Srinivasa R. Idiopathic CD4 lymphocytopenia in neurological disorders","volume":"195","author":"Gupta","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578248_bb0100","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1086\/318120","article-title":"Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases","volume":"31","author":"Haider","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578248_bb0105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s13365-018-0657-x","article-title":"Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia","volume":"24","author":"Harel","year":"2018","journal-title":"J. Neurovirol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2023.578248_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jns.2007.12.015","article-title":"Progressive multifocal leukoencephalopathy and CD4+ T-lymphocytopenia in a patient with Sj\u00f6gren syndrome","volume":"268","author":"Hayashi","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578248_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archderm.143.5.673","article-title":"Disseminated cutaneous Kaposi sarcoma and progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia","volume":"143","author":"Inhoff","year":"2007","journal-title":"Arch. Dermatol."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578248_bb0120","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/jnnp.64.6.788","article-title":"An unusual course of progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia","volume":"64","author":"Iwase","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578248_bb0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5692\/clinicalneurol.cn-000552","article-title":"A case of cerebellar brainstem form of progressive multifocal leukoencephalopathy associated with idiopathic CD4+ lymphocytopenia","volume":"55","author":"Izaki","year":"2015","journal-title":"Rinsho Shinkeigaku"},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578248_bb0130","doi-asserted-by":"crossref","first-page":"750","DOI":"10.5692\/clinicalneurol.cn-001227","article-title":"Idiopathic CD4-positive lymphocytopenia-associated progressive multifocal leukoencephalopathy confirmed by brain biopsy following negative results of repeated CSF-JC-virus tests: a case report","volume":"58","author":"Kano","year":"2018","journal-title":"Rinsho Shinkeigaku"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2023.578248_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jns.2012.11.004","article-title":"Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection","volume":"324","author":"Kobayashi","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578248_bb0140","unstructured":"Kokubun N, Ishihara T, Nishibayashi M, Ikeda S, Nagashima K, Hirata K. Progressive multifocal leukoencephalopathy with idiopathic CD4 positive T-lymphocytepenia mimicking a low grade glioma on proton MR spectroscopy. A case report. Rinsho Shinkeigaku. 2005 Sep;45(9):663\u20138. Japanese. PMID: 16248399."},{"key":"10.1016\/j.jneuroim.2023.578248_bb0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ana.26307","article-title":"Outcome of progressive multifocal leukoencephalopathy treated by Interleukin-7","volume":"91","author":"Lajaunie","year":"2022","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578248_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/1756-185X.13444","article-title":"Association of good oncological response to therapy with the development of rheumatic immune-related adverse events following PD-1 inhibitor therapy","volume":"22","author":"Liew","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"issue":"18","key":"10.1016\/j.jneuroim.2023.578248_bb0155","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2202348","article-title":"Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 years","volume":"388","author":"Lisco","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578248_bb0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1574-695X.2008.00490.x","article-title":"Idiopathic CD4 lymphocytopenia and opportunistic infection--an update","volume":"54","author":"Luo","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jneuroim.2023.578248_bb0165","unstructured":"Melzi S, Bonfanti P, Carenzi L, Faggion I, Resta M, Resta F, Rizzardini G. Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ cells deficit. Clin. Ter. 2008 Sep-Oct;159(5):325-7. (PMID: 18998035)."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578248_bb0170","first-page":"84","article-title":"Progressive multifocal leucoencephalopathy in a patient with idiopathic CD4+ lymphocytopenia","volume":"105","author":"Moloney","year":"2012","journal-title":"Ir. Med. J."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578248_bb0175","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4103\/neuroindia.NI_535_16","article-title":"Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine","volume":"65","author":"Nambirajan","year":"2017","journal-title":"Neurol. India"},{"key":"10.1016\/j.jneuroim.2023.578248_bb0180","article-title":"A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia","volume":"65","author":"Patel","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578248_bb0185","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/v14050970","article-title":"Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in people living with HIV","volume":"14","author":"Pinnetti","year":"2022","journal-title":"Viruses."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578248_bb0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0028-3886.60423","article-title":"Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+T lymphocytopenia","volume":"58","author":"Puri","year":"2010","journal-title":"Neurol. India"},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578248_bb0195","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1086\/500400","article-title":"Long-term remission in progressive multifocal leukoencephalopathy caused by idiopathic CD4+ T lymphocytopenia: a case report","volume":"42","author":"Rueger","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578248_bb0200","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QAD.0000000000003118","article-title":"Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab","volume":"36","author":"Sim","year":"2022","journal-title":"AIDS."},{"key":"10.1016\/j.jneuroim.2023.578248_bb0210","doi-asserted-by":"crossref","unstructured":"Sutton P, Raslau F, Sudhakar P. A rare Case of Cerebellar Progressive Multifocal Leukoencephalopathy due to Idiopathic CD4 Lymphocytopenia. Mult. Scler. Relat. Disord. 2020 Nov;46:102531. doi: https:\/\/doi.org\/10.1016\/j.msard.2020.102531. Epub 2020 Sep 24. PMID: 33002678.","DOI":"10.1016\/j.msard.2020.102531"},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578248_bb0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/QAI.0b013e31825a313c","article-title":"Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy","volume":"60","author":"Tan","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jneuroim.2023.578248_bb0225","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMc1816198","article-title":"Treatment of progressive multifocal leukoencephalopathy with nivolumab","volume":"380","author":"Walter","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578248_bb0230","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578248_bb0235","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24371","article-title":"Persistence and pathogenesis of the neurotropic polyomavirus JC","volume":"77","author":"Wollebo","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578248_bb0240","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000497155","article-title":"Pembrolizumab-Induced Immune-Mediated Colitis in a Patient with concurrent Clostridium Difficile Infection","volume":"12","author":"Zhou","year":"2019","journal-title":"Case Rep Oncol."},{"key":"10.1016\/j.jneuroim.2023.578248_bb0245","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","article-title":"Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors","volume":"112","author":"Zonios","year":"2008","journal-title":"Blood"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:58:07Z","timestamp":1736366287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823002345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":47,"alternative-id":["S0165572823002345"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578248","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578248"}}